drugset / Trial / NCT03951649

Acute Headache Treatment in Pregnancy: Occipital Nerve Block vs PO Acetaminophen With Caffeine

NCT03951649

Phase 4 Completed 62 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open label randomized controlled trial evaluating response to bupivacaine occipital nerve block compared to Tylenol/Caffeine cocktail in treatment of pregnant patients seeking care of headache.

Timeline

Start
2020-02-10
Primary completion
2022-12-31
Completion
2022-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 5 ml Other
Subject Caffeine Small molecule 100 mg Oral